Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jun 21, 2016 at 9:10 AM EDT

Global Blood Therapeutics Rises After Pricing Secondary Offering

Global Blood Therapeutics shares saw a handy gain in the premarket on Tuesday, despite the company pricing its secondary offering…

Lee Jackson | Jun 21, 2016 at 8:35 AM EDT

4 Red-Hot Biotech Stocks With Over 100% Upside Potential

These four biotech companies not only have data that could prove to be huge, but they have been absolutely hammered…

Chris Lange | Jun 20, 2016 at 12:25 PM EDT

Gilead Sciences Bounces on Preliminary Results

Shares of Gilead Sciences Inc. (NASDAQ: GILD) saw make a handy gain just off of their 52-week low following the release of…

Chris Lange | Jun 20, 2016 at 11:15 AM EDT

Selecta Biosciences Closes in on IPO

Selecta Biosciences intends to price more than 4 million shares in the range of $14 to $16 per share for…

Chris Lange | Jun 20, 2016 at 11:10 AM EDT

Syros Pharmaceuticals Announces Potential Pricing for IPO

Syros Pharmaceuticals expects to price 4 million shares in the range of $14 to $16 per share in an intial…

Chris Lange | Jun 20, 2016 at 9:10 AM EDT

How Inovio Pharma Is Joining the Fight Against the Zika Virus

Inovio Pharmaceuticals has announced that it received approval to initiate a Phase 1 human trial to evaluate its Zika DNA…

Chris Lange | Jun 20, 2016 at 8:40 AM EDT

Could This Be a Turning Point for Fate Therapeutics?

Shares of Fate Therapeutics saw a healthy gain early on Monday following a key U.S. Food and Drug Administration (FDA)…

Chris Lange | Jun 17, 2016 at 10:05 AM EDT

Paratek Makes Milestone Movement in Late-Stage Trial

Paratek Pharmaceuticals saw its shares take a solid jump early on Friday after the results from its late-stage trial were…

Chris Lange | Jun 16, 2016 at 10:15 AM EDT

Tonix Pharmaceuticals Prices Secondary Offering

Shares of Tonix Pharmaceuticals slid in Thursday’s session after the company announced the pricing of its secondary offering.

Chris Lange | Jun 15, 2016 at 11:05 AM EDT

6 Biopharma Movers Making a Run on Wednesday

24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in…

Trey Thoelcke | Jun 15, 2016 at 7:15 AM EDT

Some Popular Obamacare Plans About to See Big Price Hikes?

Users of some popular Affordable Care Act plans may face sticker shock in the coming year, according to a study…

Chris Lange | Jun 14, 2016 at 12:10 PM EDT

Revance Therapeutics Drops on Missed Late Stage Results

Revance Therapeutics hit a new 52-week low in Tuesday’s session following the release of its late stage trial results.

Chris Lange | Jun 14, 2016 at 11:15 AM EDT

Why Infinity Pharmaceuticals Crashed

Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still…

Chris Lange | Jun 14, 2016 at 11:05 AM EDT

Zimmer Biomet Prices Secondary Offering

Zimmer Biomet saw its shares slide in Tuesday's session after the company announced the pricing of its previously disclosed underwritten…

Chris Lange | Jun 14, 2016 at 9:55 AM EDT

Pfizer and Shire Move on IBD License Agreement

Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.

1 … 205 206 207 208 209 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Global Blood Therapeutics Rises After Pricing Secondary Offering

4 Red-Hot Biotech Stocks With Over 100% Upside Potential

Gilead Sciences Bounces on Preliminary Results

Selecta Biosciences Closes in on IPO

Syros Pharmaceuticals Announces Potential Pricing for IPO

How Inovio Pharma Is Joining the Fight Against the Zika Virus

Could This Be a Turning Point for Fate Therapeutics?

Paratek Makes Milestone Movement in Late-Stage Trial

Tonix Pharmaceuticals Prices Secondary Offering

6 Biopharma Movers Making a Run on Wednesday

Some Popular Obamacare Plans About to See Big Price Hikes?

Revance Therapeutics Drops on Missed Late Stage Results

Why Infinity Pharmaceuticals Crashed

Zimmer Biomet Prices Secondary Offering

Pfizer and Shire Move on IBD License Agreement

A $480,000 Portfolio That Showers You With $36,000 a Year Without Touching Principal

Wall Street’s $800 Billion AI Data Center Bet Is Showing Cracks. Only 84 of 157 Gigawatts Will Be Built by 2030

How XDTE Pays Friday Income on the S&P 500 With a 0DTE Covered Call Strategy

A $480,000 Portfolio That Showers You With $36,000 a Year Without Touching Principal

Dave Ramsey's Shotgun-Wedding Advice to a Pregnant Caller Who Paid Off $80K in Debt

A $480,000 Portfolio That Showers You With $36,000 a Year Without Touching Principal

Wall Street’s $800 Billion AI Data Center Bet Is Showing Cracks. Only 84 of 157 Gigawatts Will Be Built by 2030

Health and Healthcare Articles

All Health and Healthcare Articles

Global Blood Therapeutics Rises After Pricing Secondary Offering

4 Red-Hot Biotech Stocks With Over 100% Upside Potential

Gilead Sciences Bounces on Preliminary Results

Selecta Biosciences Closes in on IPO

Syros Pharmaceuticals Announces Potential Pricing for IPO

How Inovio Pharma Is Joining the Fight Against the Zika Virus

Could This Be a Turning Point for Fate Therapeutics?

Paratek Makes Milestone Movement in Late-Stage Trial

Tonix Pharmaceuticals Prices Secondary Offering

6 Biopharma Movers Making a Run on Wednesday

Some Popular Obamacare Plans About to See Big Price Hikes?

Revance Therapeutics Drops on Missed Late Stage Results

Why Infinity Pharmaceuticals Crashed

Zimmer Biomet Prices Secondary Offering

Pfizer and Shire Move on IBD License Agreement

A $480,000 Portfolio That Showers You With $36,000 a Year Without Touching Principal

Wall Street’s $800 Billion AI Data Center Bet Is Showing Cracks. Only 84 of 157 Gigawatts Will Be Built by 2030

How XDTE Pays Friday Income on the S&P 500 With a 0DTE Covered Call Strategy

Featured Reads

A $480,000 Portfolio That Showers You With $36,000 a Year Without Touching Principal

Dave Ramsey's Shotgun-Wedding Advice to a Pregnant Caller Who Paid Off $80K in Debt